Top Fibromyalgia Drug Tanks: Four Other Drugs On Way
Tomnya had everything going for it; a novel approach to pain and good Phase II trial results, but Tonix’s reformulation of Flexeril that was expected to help with both sleep and pain tanked in its critical Phase III trial. Check out what happened with it, and...
A Genetic Panel For Fibromyalgia? The new Proove Genetic Test
The Proove genetic test for fibromyalgia – is the first genetic test that I know of for FM. It’s not a diagnostic test – it’s focused on guiding treatment options. It identifies ten genes that can affect drug metabolism and one gene that affects...
Data analysis Puts PACE Chronic Fatigue Syndrome Trial on Slippery Slope to Retraction
The issue at stake was a big one. It asked whether changes to the original protocol of the PACE trial ended up stacking the deck. It was easy to see how they might have; some of the recovery criteria were so weird as to seem ridiculous. The changes in the studies...
“A Nation in Pain: Healing Our Biggest Health Problem” – A Review
Chronic pain costs more than heart disease, cancer and diabetes combined yet gets a fraction of their funding. Judy Foreman knows well the cost of our medical systems dysfunctional approach to pain. A medical journalist used to good medical care, she was dismayed by...
Ampligen Takes Big Step Forward – Becomes First Drug Approved Anywhere For Chronic Fatigue Syndrome
Ampligen became the first drug ever approved for use in ME/CFS when ANMAT, Argentine’s FDA, approved the drug for use in severe ME/CFS patients. The approval should provide a clear pathway for Ampligen’s approval elsewhere. The U.S. is the odd man out in...Lives Interrupted Latest Story
Megan
Randolph, United States
Former occupation: Day care worker
$562,824
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
